Current Value of Holding

$0

Shares

0

% of Portfolio

0.00%

Average Buy Price

$18.5

Avg closing price
Price range

2 Jim Simons Apimeds Pharmaceuticals US Trades

Jim Simons started to build up the position in Apimeds Pharmaceuticals US in Q3 2025. Since then they sold 278 shares. The investor sold all their shares in Q4 2025 and doesn't own any shares in Apimeds Pharmaceuticals US anymore.

Avg closing price
Price range
Sold -278 shares Q4 2025
Avg closing price $21.33
Price range $15.20 - $39.00
New holding (+278 shares) Q3 2025
Avg closing price $18.52
Price range $15.30 - $22.70

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!